# EDGAR Filing Document

**Accession Number:** 0001131399
**File Stem:** 0001654954-23-001568
**Filing Date:** 2023-2
**Character Count:** 32133
**Document Hash:** 5aa25cf01e7419ccedae3ea64ba64d29
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001654954-23-001568.hdr.sgml**: 20230210

**ACCESSION NUMBER**: 0001654954-23-001568

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20230210

**FILED AS OF DATE**: 20230210

**DATE AS OF CHANGE**: 20230210

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** GSK PLC
- **CENTRAL INDEX KEY:** 0001131399
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** X0

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-15170
- **FILM NUMBER:** 23610266

**BUSINESS ADDRESS:**
- **STREET 1:** 980 GREAT WEST ROAD
- **CITY:** BRENTFORD MIDDLESEX
- **STATE:** X0
- **ZIP:** TW8 9GS
- **BUSINESS PHONE:** 011442080475000

**MAIL ADDRESS:**
- **STREET 1:** 980 GREAT WEST ROAD
- **CITY:** BRENTFORD MIDDLESEX
- **STATE:** X0
- **ZIP:** TW8 9GS

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** GLAXOSMITHKLINE PLC
- **DATE OF NAME CHANGE:** 20010105

**UNITED STATES**

 **SECURITIES AND EXCHANGE COMMISSION**

 **Washington, D.C. 20549**

 **Form 6-K**

 **REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16**

 **UNDER THE SECURITIES EXCHANGE ACT OF 1934**

For the month of February 2023

Commission File Number 001-15170

 **GSK plc**

(Translation of registrant's name into English)

 **980 Great West Road, Brentford, Middlesex, TW8 9GS**

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F . . . .X. . . . Form 40-F . . . . . . . .

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____

 **GSK plc (the 'Company')**

Transaction notification

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp; **1.** | &nbsp;&nbsp;&nbsp; **Details of PDMR/person closely associated with them ('PCA')** | &nbsp;&nbsp;&nbsp; **Details of PDMR/person closely associated with them ('PCA')** | &nbsp;&nbsp;&nbsp; **Details of PDMR/person closely associated with them ('PCA')** |
| &nbsp;&nbsp;&nbsp;&nbsp; a) | &nbsp;&nbsp;&nbsp; Name | Ms E Walmsley | Ms E Walmsley |
| &nbsp;&nbsp;&nbsp;&nbsp; b) | &nbsp;&nbsp;&nbsp; Position/status | Chief Executive Officer | Chief Executive Officer |
| &nbsp;&nbsp;&nbsp;&nbsp; c) | &nbsp;&nbsp;&nbsp; Initial notification/amendment | Initial notification | Initial notification |
| &nbsp;&nbsp;&nbsp;&nbsp; **2.** | &nbsp;&nbsp;&nbsp; **Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor** | &nbsp;&nbsp;&nbsp; **Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor** | &nbsp;&nbsp;&nbsp; **Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor** |
| &nbsp;&nbsp;&nbsp;&nbsp; a) | &nbsp;&nbsp;&nbsp; Name | GSK plc | GSK plc |
| &nbsp;&nbsp;&nbsp;&nbsp; b) | &nbsp;&nbsp;&nbsp; LEI | 5493000HZTVUYLO1D793 | 5493000HZTVUYLO1D793 |
| &nbsp;&nbsp;&nbsp;&nbsp; **3.** | &nbsp;&nbsp;&nbsp; **Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted** | &nbsp;&nbsp;&nbsp; **Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted** | &nbsp;&nbsp;&nbsp; **Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted** |
| &nbsp;&nbsp;&nbsp;&nbsp; a) | &nbsp;&nbsp;&nbsp; Description of the financial instrument | Ordinary shares of 31 ¼ pence each ('Ordinary Shares')<br> ISIN: GB00BN7SWP63 | Ordinary shares of 31 ¼ pence each ('Ordinary Shares')<br> ISIN: GB00BN7SWP63 |
| &nbsp;&nbsp;&nbsp;&nbsp; b) | &nbsp;&nbsp;&nbsp; Nature of the transaction | Acquisition of Ordinary Shares under the Company's Share Reward Plan | Acquisition of Ordinary Shares under the Company's Share Reward Plan |
| &nbsp;&nbsp;&nbsp;&nbsp; c) | &nbsp;&nbsp;&nbsp; Price(s) and volume(s) | Price(s) | Volume(s) |
| &nbsp;&nbsp;&nbsp;&nbsp; c) | &nbsp;&nbsp;&nbsp; Price(s) and volume(s) | £15.1396 | 8 (partnership shares) |
| &nbsp;&nbsp;&nbsp;&nbsp; c) | &nbsp;&nbsp;&nbsp; Price(s) and volume(s) | £15.1396 | 8 (matching shares) |
| &nbsp;&nbsp;&nbsp;&nbsp; d) | &nbsp;&nbsp;&nbsp; Aggregated information<br>|  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; d) | &nbsp;&nbsp;&nbsp; Aggregated volume<br> Price<br>| 16 Ordinary Shares<br> £15.1396 | 16 Ordinary Shares<br> £15.1396 |
| &nbsp;&nbsp;&nbsp;&nbsp; e) | &nbsp;&nbsp;&nbsp; Date of the transaction | 2023-02-09 | 2023-02-09 |
| &nbsp;&nbsp;&nbsp;&nbsp; f) | &nbsp;&nbsp;&nbsp; Place of the transaction<br>| London Stock Exchange (XLON) | London Stock Exchange (XLON) |

---

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp; **1.** | &nbsp;&nbsp;&nbsp; **Details of PDMR/person closely associated with them ('PCA')** | &nbsp;&nbsp;&nbsp; **Details of PDMR/person closely associated with them ('PCA')** | &nbsp;&nbsp;&nbsp; **Details of PDMR/person closely associated with them ('PCA')** |
| &nbsp;&nbsp;&nbsp;&nbsp; a) | &nbsp;&nbsp;&nbsp; Name | Mr J Ford | Mr J Ford |
| &nbsp;&nbsp;&nbsp;&nbsp; b) | &nbsp;&nbsp;&nbsp; Position/status | SVP and Group General Counsel, Legal and Compliance | SVP and Group General Counsel, Legal and Compliance |
| &nbsp;&nbsp;&nbsp;&nbsp; c) | &nbsp;&nbsp;&nbsp; Initial notification/amendment | Initial notification | Initial notification |
| &nbsp;&nbsp;&nbsp;&nbsp; **2.** | &nbsp;&nbsp;&nbsp; **Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor** | &nbsp;&nbsp;&nbsp; **Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor** | &nbsp;&nbsp;&nbsp; **Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor** |
| &nbsp;&nbsp;&nbsp;&nbsp; a) | &nbsp;&nbsp;&nbsp; Name | GSK plc | GSK plc |
| &nbsp;&nbsp;&nbsp;&nbsp; b) | &nbsp;&nbsp;&nbsp; LEI | 5493000HZTVUYLO1D793 | 5493000HZTVUYLO1D793 |
| &nbsp;&nbsp;&nbsp;&nbsp; **3.** | &nbsp;&nbsp;&nbsp; **Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted** | &nbsp;&nbsp;&nbsp; **Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted** | &nbsp;&nbsp;&nbsp; **Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted** |
| &nbsp;&nbsp;&nbsp;&nbsp; a) | &nbsp;&nbsp;&nbsp; Description of the financial instrument | Ordinary shares of 31 ¼ pence each ('Ordinary Shares')<br> ISIN: GB00BN7SWP63 | Ordinary shares of 31 ¼ pence each ('Ordinary Shares')<br> ISIN: GB00BN7SWP63 |
| &nbsp;&nbsp;&nbsp;&nbsp; b) | &nbsp;&nbsp;&nbsp; Nature of the transaction | Acquisition of Ordinary Shares under the Company's Share Reward Plan | Acquisition of Ordinary Shares under the Company's Share Reward Plan |
| &nbsp;&nbsp;&nbsp;&nbsp; c) | &nbsp;&nbsp;&nbsp; Price(s) and volume(s) | Price(s) | Volume(s) |
| &nbsp;&nbsp;&nbsp;&nbsp; c) | &nbsp;&nbsp;&nbsp; Price(s) and volume(s) | £15.1396 | 8 (partnership shares) |
| &nbsp;&nbsp;&nbsp;&nbsp; c) | &nbsp;&nbsp;&nbsp; Price(s) and volume(s) | £15.1396 | 8 (matching shares) |
| &nbsp;&nbsp;&nbsp;&nbsp; d) | &nbsp;&nbsp;&nbsp; Aggregated information<br>|  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; d) | &nbsp;&nbsp;&nbsp; Aggregated volume<br> Price<br>| 16 Ordinary Shares<br> £15.1396 | 16 Ordinary Shares<br> £15.1396 |
| &nbsp;&nbsp;&nbsp;&nbsp; e) | &nbsp;&nbsp;&nbsp; Date of the transaction | 2023-02-09 | 2023-02-09 |
| &nbsp;&nbsp;&nbsp;&nbsp; f) | &nbsp;&nbsp;&nbsp; Place of the transaction<br>| London Stock Exchange (XLON) | London Stock Exchange (XLON) |

---

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp; **1.** | &nbsp;&nbsp;&nbsp; **Details of PDMR/person closely associated with them ('PCA')** | &nbsp;&nbsp;&nbsp; **Details of PDMR/person closely associated with them ('PCA')** | &nbsp;&nbsp;&nbsp; **Details of PDMR/person closely associated with them ('PCA')** |
| &nbsp;&nbsp;&nbsp;&nbsp; a) | &nbsp;&nbsp;&nbsp; Name | Ms S Jackson | Ms S Jackson |
| &nbsp;&nbsp;&nbsp;&nbsp; b) | &nbsp;&nbsp;&nbsp; Position/status | SVP, Global Communications and CEO Office | SVP, Global Communications and CEO Office |
| &nbsp;&nbsp;&nbsp;&nbsp; c) | &nbsp;&nbsp;&nbsp; Initial notification/amendment | Initial notification | Initial notification |
| &nbsp;&nbsp;&nbsp;&nbsp; **2.** | &nbsp;&nbsp;&nbsp; **Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor** | &nbsp;&nbsp;&nbsp; **Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor** | &nbsp;&nbsp;&nbsp; **Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor** |
| &nbsp;&nbsp;&nbsp;&nbsp; a) | &nbsp;&nbsp;&nbsp; Name | GSK plc | GSK plc |
| &nbsp;&nbsp;&nbsp;&nbsp; b) | &nbsp;&nbsp;&nbsp; LEI | 5493000HZTVUYLO1D793 | 5493000HZTVUYLO1D793 |
| &nbsp;&nbsp;&nbsp;&nbsp; **3.** | &nbsp;&nbsp;&nbsp; **Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted** | &nbsp;&nbsp;&nbsp; **Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted** | &nbsp;&nbsp;&nbsp; **Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted** |
| &nbsp;&nbsp;&nbsp;&nbsp; a) | &nbsp;&nbsp;&nbsp; Description of the financial instrument | Ordinary shares of 31 ¼ pence each ('Ordinary Shares')<br> ISIN: GB00BN7SWP63 | Ordinary shares of 31 ¼ pence each ('Ordinary Shares')<br> ISIN: GB00BN7SWP63 |
| &nbsp;&nbsp;&nbsp;&nbsp; b) | &nbsp;&nbsp;&nbsp; Nature of the transaction | Acquisition of Ordinary Shares under the Company's Share Reward Plan | Acquisition of Ordinary Shares under the Company's Share Reward Plan |
| &nbsp;&nbsp;&nbsp;&nbsp; c) | &nbsp;&nbsp;&nbsp; Price(s) and volume(s) | Price(s) | Volume(s) |
| &nbsp;&nbsp;&nbsp;&nbsp; c) | &nbsp;&nbsp;&nbsp; Price(s) and volume(s) | £15.1396 | 8 (partnership shares) |
| &nbsp;&nbsp;&nbsp;&nbsp; c) | &nbsp;&nbsp;&nbsp; Price(s) and volume(s) | £15.1396 | 8 (matching shares) |
| &nbsp;&nbsp;&nbsp;&nbsp; d) | &nbsp;&nbsp;&nbsp; Aggregated information<br>|  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; d) | &nbsp;&nbsp;&nbsp; Aggregated volume<br> Price<br>| 16 Ordinary Shares<br> £15.1396 | 16 Ordinary Shares<br> £15.1396 |
| &nbsp;&nbsp;&nbsp;&nbsp; e) | &nbsp;&nbsp;&nbsp; Date of the transaction | 2023-02-09 | 2023-02-09 |
| &nbsp;&nbsp;&nbsp;&nbsp; f) | &nbsp;&nbsp;&nbsp; Place of the transaction<br>| London Stock Exchange (XLON) | London Stock Exchange (XLON) |

---

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp; **1.** | &nbsp;&nbsp;&nbsp; **Details of PDMR/person closely associated with them ('PCA')** | &nbsp;&nbsp;&nbsp; **Details of PDMR/person closely associated with them ('PCA')** | &nbsp;&nbsp;&nbsp; **Details of PDMR/person closely associated with them ('PCA')** |
| &nbsp;&nbsp;&nbsp;&nbsp; a) | &nbsp;&nbsp;&nbsp; Name | Mr D Jackson | Mr D Jackson |
| &nbsp;&nbsp;&nbsp;&nbsp; b) | &nbsp;&nbsp;&nbsp; Position/status | PCA of Ms S Jackson (SVP, Global Communications and CEO Office) | PCA of Ms S Jackson (SVP, Global Communications and CEO Office) |
| &nbsp;&nbsp;&nbsp;&nbsp; c) | &nbsp;&nbsp;&nbsp; Initial notification/amendment | Initial notification | Initial notification |
| &nbsp;&nbsp;&nbsp;&nbsp; **2.** | &nbsp;&nbsp;&nbsp; **Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor** | &nbsp;&nbsp;&nbsp; **Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor** | &nbsp;&nbsp;&nbsp; **Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor** |
| &nbsp;&nbsp;&nbsp;&nbsp; a) | &nbsp;&nbsp;&nbsp; Name | GSK plc | GSK plc |
| &nbsp;&nbsp;&nbsp;&nbsp; b) | &nbsp;&nbsp;&nbsp; LEI | 5493000HZTVUYLO1D793 | 5493000HZTVUYLO1D793 |
| &nbsp;&nbsp;&nbsp;&nbsp; **3.** | &nbsp;&nbsp;&nbsp; **Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted** | &nbsp;&nbsp;&nbsp; **Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted** | &nbsp;&nbsp;&nbsp; **Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted** |
| &nbsp;&nbsp;&nbsp;&nbsp; a) | &nbsp;&nbsp;&nbsp; Description of the financial instrument | Ordinary shares of 31 ¼ pence each ('Ordinary Shares')<br> ISIN: GB00BN7SWP63 | Ordinary shares of 31 ¼ pence each ('Ordinary Shares')<br> ISIN: GB00BN7SWP63 |
| &nbsp;&nbsp;&nbsp;&nbsp; b) | &nbsp;&nbsp;&nbsp; Nature of the transaction | Acquisition of Ordinary Shares under the Company's Share Reward Plan | Acquisition of Ordinary Shares under the Company's Share Reward Plan |
| &nbsp;&nbsp;&nbsp;&nbsp; c) | &nbsp;&nbsp;&nbsp; Price(s) and volume(s) | Price(s) | Volume(s) |
| &nbsp;&nbsp;&nbsp;&nbsp; c) | &nbsp;&nbsp;&nbsp; Price(s) and volume(s) | £15.1396 | 9 (partnership shares) |
| &nbsp;&nbsp;&nbsp;&nbsp; c) | &nbsp;&nbsp;&nbsp; Price(s) and volume(s) | £15.1396 | 9 (matching shares) |
| &nbsp;&nbsp;&nbsp;&nbsp; d) | &nbsp;&nbsp;&nbsp; Aggregated information<br>|  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; d) | &nbsp;&nbsp;&nbsp; Aggregated volume<br> Price<br>| 18 Ordinary Shares<br> £15.1396 | 18 Ordinary Shares<br> £15.1396 |
| &nbsp;&nbsp;&nbsp;&nbsp; e) | &nbsp;&nbsp;&nbsp; Date of the transaction | 2023-02-09 | 2023-02-09 |
| &nbsp;&nbsp;&nbsp;&nbsp; f) | &nbsp;&nbsp;&nbsp; Place of the transaction<br>| London Stock Exchange (XLON) | London Stock Exchange (XLON) |

---

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp; **1.** | &nbsp;&nbsp;&nbsp; **Details of PDMR/person closely associated with them ('PCA')** | &nbsp;&nbsp;&nbsp; **Details of PDMR/person closely associated with them ('PCA')** | &nbsp;&nbsp;&nbsp; **Details of PDMR/person closely associated with them ('PCA')** |
| &nbsp;&nbsp;&nbsp;&nbsp; a) | &nbsp;&nbsp;&nbsp; Name | Mr D Redfern | Mr D Redfern |
| &nbsp;&nbsp;&nbsp;&nbsp; b) | &nbsp;&nbsp;&nbsp; Position/status | President Corporate Development | President Corporate Development |
| &nbsp;&nbsp;&nbsp;&nbsp; c) | &nbsp;&nbsp;&nbsp; Initial notification/amendment | Initial notification | Initial notification |
| &nbsp;&nbsp;&nbsp;&nbsp; **2.** | &nbsp;&nbsp;&nbsp; **Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor** | &nbsp;&nbsp;&nbsp; **Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor** | &nbsp;&nbsp;&nbsp; **Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor** |
| &nbsp;&nbsp;&nbsp;&nbsp; a) | &nbsp;&nbsp;&nbsp; Name | GSK plc | GSK plc |
| &nbsp;&nbsp;&nbsp;&nbsp; b) | &nbsp;&nbsp;&nbsp; LEI | 5493000HZTVUYLO1D793 | 5493000HZTVUYLO1D793 |
| &nbsp;&nbsp;&nbsp;&nbsp; **3.** | &nbsp;&nbsp;&nbsp; **Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted** | &nbsp;&nbsp;&nbsp; **Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted** | &nbsp;&nbsp;&nbsp; **Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted** |
| &nbsp;&nbsp;&nbsp;&nbsp; a) | &nbsp;&nbsp;&nbsp; Description of the financial instrument | Ordinary shares of 31 ¼ pence each ('Ordinary Shares')<br> ISIN: GB00BN7SWP63 | Ordinary shares of 31 ¼ pence each ('Ordinary Shares')<br> ISIN: GB00BN7SWP63 |
| &nbsp;&nbsp;&nbsp;&nbsp; b) | &nbsp;&nbsp;&nbsp; Nature of the transaction | Acquisition of Ordinary Shares under the Company's Share Reward Plan | Acquisition of Ordinary Shares under the Company's Share Reward Plan |
| &nbsp;&nbsp;&nbsp;&nbsp; c) | &nbsp;&nbsp;&nbsp; Price(s) and volume(s) | Price(s) | Volume(s) |
| &nbsp;&nbsp;&nbsp;&nbsp; c) | &nbsp;&nbsp;&nbsp; Price(s) and volume(s) | £15.1396 | 8 (partnership shares) |
| &nbsp;&nbsp;&nbsp;&nbsp; c) | &nbsp;&nbsp;&nbsp; Price(s) and volume(s) | £15.1396 | 8 (matching shares) |
| &nbsp;&nbsp;&nbsp;&nbsp; d) | &nbsp;&nbsp;&nbsp; Aggregated information<br>|  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; d) | &nbsp;&nbsp;&nbsp; Aggregated volume<br> Price<br>| 16 Ordinary Shares<br> £15.1396 | 16 Ordinary Shares<br> £15.1396 |
| &nbsp;&nbsp;&nbsp;&nbsp; e) | &nbsp;&nbsp;&nbsp; Date of the transaction | 2023-02-09 | 2023-02-09 |
| &nbsp;&nbsp;&nbsp;&nbsp; f) | &nbsp;&nbsp;&nbsp; Place of the transaction<br>| London Stock Exchange (XLON) | London Stock Exchange (XLON) |

---

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp; **1.** | &nbsp;&nbsp;&nbsp; **Details of PDMR/person closely associated with them ('PCA')** | &nbsp;&nbsp;&nbsp; **Details of PDMR/person closely associated with them ('PCA')** | &nbsp;&nbsp;&nbsp; **Details of PDMR/person closely associated with them ('PCA')** |
| &nbsp;&nbsp;&nbsp;&nbsp; a) | &nbsp;&nbsp;&nbsp; Name | Mr R Simard | Mr R Simard |
| &nbsp;&nbsp;&nbsp;&nbsp; b) | &nbsp;&nbsp;&nbsp; Position/status | President, Global Supply Chain | President, Global Supply Chain |
| &nbsp;&nbsp;&nbsp;&nbsp; c) | &nbsp;&nbsp;&nbsp; Initial notification/amendment | Initial notification | Initial notification |
| &nbsp;&nbsp;&nbsp;&nbsp; **2.** | &nbsp;&nbsp;&nbsp; **Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor** | &nbsp;&nbsp;&nbsp; **Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor** | &nbsp;&nbsp;&nbsp; **Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor** |
| &nbsp;&nbsp;&nbsp;&nbsp; a) | &nbsp;&nbsp;&nbsp; Name | GSK plc | GSK plc |
| &nbsp;&nbsp;&nbsp;&nbsp; b) | &nbsp;&nbsp;&nbsp; LEI | 5493000HZTVUYLO1D793 | 5493000HZTVUYLO1D793 |
| &nbsp;&nbsp;&nbsp;&nbsp; **3.** | &nbsp;&nbsp;&nbsp; **Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted** | &nbsp;&nbsp;&nbsp; **Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted** | &nbsp;&nbsp;&nbsp; **Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted** |
| &nbsp;&nbsp;&nbsp;&nbsp; a) | &nbsp;&nbsp;&nbsp; Description of the financial instrument | Ordinary shares of 31 ¼ pence each ('Ordinary Shares')<br> ISIN: GB00BN7SWP63 | Ordinary shares of 31 ¼ pence each ('Ordinary Shares')<br> ISIN: GB00BN7SWP63 |
| &nbsp;&nbsp;&nbsp;&nbsp; b) | &nbsp;&nbsp;&nbsp; Nature of the transaction | Acquisition of Ordinary Shares under the Company's Share Reward Plan | Acquisition of Ordinary Shares under the Company's Share Reward Plan |
| &nbsp;&nbsp;&nbsp;&nbsp; c) | &nbsp;&nbsp;&nbsp; Price(s) and volume(s) | Price(s) | Volume(s) |
| &nbsp;&nbsp;&nbsp;&nbsp; c) | &nbsp;&nbsp;&nbsp; Price(s) and volume(s) | £15.1396 | 9 (partnership shares) |
| &nbsp;&nbsp;&nbsp;&nbsp; c) | &nbsp;&nbsp;&nbsp; Price(s) and volume(s) | £15.1396 | 9 (matching shares) |
| &nbsp;&nbsp;&nbsp;&nbsp; d) | &nbsp;&nbsp;&nbsp; Aggregated information<br>|  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; d) | &nbsp;&nbsp;&nbsp; Aggregated volume<br> Price<br>| 18 Ordinary Shares<br> £15.1396 | 18 Ordinary Shares<br> £15.1396 |
| &nbsp;&nbsp;&nbsp;&nbsp; e) | &nbsp;&nbsp;&nbsp; Date of the transaction | 2023-02-09 | 2023-02-09 |
| &nbsp;&nbsp;&nbsp;&nbsp; f) | &nbsp;&nbsp;&nbsp; Place of the transaction<br>| London Stock Exchange (XLON) | London Stock Exchange (XLON) |

---

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp; **1.** | &nbsp;&nbsp;&nbsp; **Details of PDMR/person closely associated with them ('PCA')** | &nbsp;&nbsp;&nbsp; **Details of PDMR/person closely associated with them ('PCA')** | &nbsp;&nbsp;&nbsp; **Details of PDMR/person closely associated with them ('PCA')** |
| &nbsp;&nbsp;&nbsp;&nbsp; a) | &nbsp;&nbsp;&nbsp; Name | Mr P Thomson | Mr P Thomson |
| &nbsp;&nbsp;&nbsp;&nbsp; b) | &nbsp;&nbsp;&nbsp; Position/status | President, Global Affairs | President, Global Affairs |
| &nbsp;&nbsp;&nbsp;&nbsp; c) | &nbsp;&nbsp;&nbsp; Initial notification/amendment | Initial notification | Initial notification |
| &nbsp;&nbsp;&nbsp;&nbsp; **2.** | &nbsp;&nbsp;&nbsp; **Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor** | &nbsp;&nbsp;&nbsp; **Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor** | &nbsp;&nbsp;&nbsp; **Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor** |
| &nbsp;&nbsp;&nbsp;&nbsp; a) | &nbsp;&nbsp;&nbsp; Name | GSK plc | GSK plc |
| &nbsp;&nbsp;&nbsp;&nbsp; b) | &nbsp;&nbsp;&nbsp; LEI | 5493000HZTVUYLO1D793 | 5493000HZTVUYLO1D793 |
| &nbsp;&nbsp;&nbsp;&nbsp; **3.** | &nbsp;&nbsp;&nbsp; **Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted** | &nbsp;&nbsp;&nbsp; **Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted** | &nbsp;&nbsp;&nbsp; **Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted** |
| &nbsp;&nbsp;&nbsp;&nbsp; a) | &nbsp;&nbsp;&nbsp; Description of the financial instrument | Ordinary shares of 31 ¼ pence each ('Ordinary Shares')<br> ISIN: GB00BN7SWP63 | Ordinary shares of 31 ¼ pence each ('Ordinary Shares')<br> ISIN: GB00BN7SWP63 |
| &nbsp;&nbsp;&nbsp;&nbsp; b) | &nbsp;&nbsp;&nbsp; Nature of the transaction | Acquisition of Ordinary Shares under the Company's Share Reward Plan | Acquisition of Ordinary Shares under the Company's Share Reward Plan |
| &nbsp;&nbsp;&nbsp;&nbsp; c) | &nbsp;&nbsp;&nbsp; Price(s) and volume(s) | Price(s) | Volume(s) |
| &nbsp;&nbsp;&nbsp;&nbsp; c) | &nbsp;&nbsp;&nbsp; Price(s) and volume(s) | £15.1396 | 8 (partnership shares) |
| &nbsp;&nbsp;&nbsp;&nbsp; c) | &nbsp;&nbsp;&nbsp; Price(s) and volume(s) | £15.1396 | 8 (matching shares) |
| &nbsp;&nbsp;&nbsp;&nbsp; d) | &nbsp;&nbsp;&nbsp; Aggregated information<br>|  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; d) | &nbsp;&nbsp;&nbsp; Aggregated volume<br> Price<br>| 16 Ordinary Shares<br> £15.1396 | 16 Ordinary Shares<br> £15.1396 |
| &nbsp;&nbsp;&nbsp;&nbsp; e) | &nbsp;&nbsp;&nbsp; Date of the transaction | 2023-02-09 | 2023-02-09 |
| &nbsp;&nbsp;&nbsp;&nbsp; f) | &nbsp;&nbsp;&nbsp; Place of the transaction<br>| London Stock Exchange (XLON) | London Stock Exchange (XLON) |

---

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp; **1.** | &nbsp;&nbsp;&nbsp; **Details of PDMR/person closely associated with them ('PCA')** | &nbsp;&nbsp;&nbsp; **Details of PDMR/person closely associated with them ('PCA')** | &nbsp;&nbsp;&nbsp; **Details of PDMR/person closely associated with them ('PCA')** |
| &nbsp;&nbsp;&nbsp;&nbsp; a) | &nbsp;&nbsp;&nbsp; Name | Ms D Waterhouse | Ms D Waterhouse |
| &nbsp;&nbsp;&nbsp;&nbsp; b) | &nbsp;&nbsp;&nbsp; Position/status | CEO, ViiV Healthcare and President, Global Health, GSK | CEO, ViiV Healthcare and President, Global Health, GSK |
| &nbsp;&nbsp;&nbsp;&nbsp; c) | &nbsp;&nbsp;&nbsp; Initial notification/amendment | Initial notification | Initial notification |
| &nbsp;&nbsp;&nbsp;&nbsp; **2.** | &nbsp;&nbsp;&nbsp; **Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor** | &nbsp;&nbsp;&nbsp; **Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor** | &nbsp;&nbsp;&nbsp; **Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor** |
| &nbsp;&nbsp;&nbsp;&nbsp; a) | &nbsp;&nbsp;&nbsp; Name | GSK plc | GSK plc |
| &nbsp;&nbsp;&nbsp;&nbsp; b) | &nbsp;&nbsp;&nbsp; LEI | 5493000HZTVUYLO1D793 | 5493000HZTVUYLO1D793 |
| &nbsp;&nbsp;&nbsp;&nbsp; **3.** | &nbsp;&nbsp;&nbsp; **Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted** | &nbsp;&nbsp;&nbsp; **Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted** | &nbsp;&nbsp;&nbsp; **Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted** |
| &nbsp;&nbsp;&nbsp;&nbsp; a) | &nbsp;&nbsp;&nbsp; Description of the financial instrument | Ordinary shares of 31 ¼ pence each ('Ordinary Shares')<br> ISIN: GB00BN7SWP63 | Ordinary shares of 31 ¼ pence each ('Ordinary Shares')<br> ISIN: GB00BN7SWP63 |
| &nbsp;&nbsp;&nbsp;&nbsp; b) | &nbsp;&nbsp;&nbsp; Nature of the transaction | Acquisition of Ordinary Shares under the Company's Share Reward Plan | Acquisition of Ordinary Shares under the Company's Share Reward Plan |
| &nbsp;&nbsp;&nbsp;&nbsp; c) | &nbsp;&nbsp;&nbsp; Price(s) and volume(s) | Price(s) | Volume(s) |
| &nbsp;&nbsp;&nbsp;&nbsp; c) | &nbsp;&nbsp;&nbsp; Price(s) and volume(s) | £15.1396 | 9 (partnership shares) |
| &nbsp;&nbsp;&nbsp;&nbsp; c) | &nbsp;&nbsp;&nbsp; Price(s) and volume(s) | £15.1396 | 9 (matching shares) |
| &nbsp;&nbsp;&nbsp;&nbsp; d) | &nbsp;&nbsp;&nbsp; Aggregated information<br>|  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; d) | &nbsp;&nbsp;&nbsp; Aggregated volume<br> Price<br>| 18 Ordinary Shares<br> £15.1396 | 18 Ordinary Shares<br> £15.1396 |
| &nbsp;&nbsp;&nbsp;&nbsp; e) | &nbsp;&nbsp;&nbsp; Date of the transaction | 2023-02-09 | 2023-02-09 |
| &nbsp;&nbsp;&nbsp;&nbsp; f) | &nbsp;&nbsp;&nbsp; Place of the transaction<br>| London Stock Exchange (XLON) | London Stock Exchange (XLON) |

---

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp; **1.** | &nbsp;&nbsp;&nbsp; **Details of PDMR/person closely associated with them ('PCA')** | &nbsp;&nbsp;&nbsp; **Details of PDMR/person closely associated with them ('PCA')** | &nbsp;&nbsp;&nbsp; **Details of PDMR/person closely associated with them ('PCA')** |
| &nbsp;&nbsp;&nbsp;&nbsp; a) | &nbsp;&nbsp;&nbsp; Name | Ms V Whyte | Ms V Whyte |
| &nbsp;&nbsp;&nbsp;&nbsp; b) | &nbsp;&nbsp;&nbsp; Position/status | Company Secretary | Company Secretary |
| &nbsp;&nbsp;&nbsp;&nbsp; c) | &nbsp;&nbsp;&nbsp; Initial notification/amendment | Initial notification | Initial notification |
| &nbsp;&nbsp;&nbsp;&nbsp; **2.** | &nbsp;&nbsp;&nbsp; **Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor** | &nbsp;&nbsp;&nbsp; **Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor** | &nbsp;&nbsp;&nbsp; **Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor** |
| &nbsp;&nbsp;&nbsp;&nbsp; a) | &nbsp;&nbsp;&nbsp; Name | GSK plc | GSK plc |
| &nbsp;&nbsp;&nbsp;&nbsp; b) | &nbsp;&nbsp;&nbsp; LEI | 5493000HZTVUYLO1D793 | 5493000HZTVUYLO1D793 |
| &nbsp;&nbsp;&nbsp;&nbsp; **3.** | &nbsp;&nbsp;&nbsp; **Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted** | &nbsp;&nbsp;&nbsp; **Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted** | &nbsp;&nbsp;&nbsp; **Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted** |
| &nbsp;&nbsp;&nbsp;&nbsp; a) | &nbsp;&nbsp;&nbsp; Description of the financial instrument | Ordinary shares of 31 ¼ pence each ('Ordinary Shares')<br> ISIN: GB00BN7SWP63 | Ordinary shares of 31 ¼ pence each ('Ordinary Shares')<br> ISIN: GB00BN7SWP63 |
| &nbsp;&nbsp;&nbsp;&nbsp; b) | &nbsp;&nbsp;&nbsp; Nature of the transaction | Acquisition of Ordinary Shares under the Company's Share Reward Plan | Acquisition of Ordinary Shares under the Company's Share Reward Plan |
| &nbsp;&nbsp;&nbsp;&nbsp; c) | &nbsp;&nbsp;&nbsp; Price(s) and volume(s) | Price(s) | Volume(s) |
| &nbsp;&nbsp;&nbsp;&nbsp; c) | &nbsp;&nbsp;&nbsp; Price(s) and volume(s) | £15.1396 | 8 (partnership shares) |
| &nbsp;&nbsp;&nbsp;&nbsp; c) | &nbsp;&nbsp;&nbsp; Price(s) and volume(s) | £15.1396 | 8 (matching shares) |
| &nbsp;&nbsp;&nbsp;&nbsp; d) | &nbsp;&nbsp;&nbsp; Aggregated information<br>|  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; d) | &nbsp;&nbsp;&nbsp; Aggregated volume<br> Price<br>| 16 Ordinary Shares<br> £15.1396 | 16 Ordinary Shares<br> £15.1396 |
| &nbsp;&nbsp;&nbsp;&nbsp; e) | &nbsp;&nbsp;&nbsp; Date of the transaction | 2023-02-09 | 2023-02-09 |
| &nbsp;&nbsp;&nbsp;&nbsp; f) | &nbsp;&nbsp;&nbsp; Place of the transaction<br>| London Stock Exchange (XLON) | London Stock Exchange (XLON) |

---

 **SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.

---

| | |
|:---|:---|
|  | **GSK plc** |
|  | (Registrant) |
| Date: February 10, 2023 |  |
|  | By:/s/ VICTORIA WHYTE<br> -------------------------- |
|  | Victoria Whyte |
|  | Authorised Signatory for and on |
|  | behalf of GSK plc |

---